Literature DB >> 31890569

Lead extraction complicated by right ventricular pseudoaneurysm: Percutaneous closure with septal occluder device.

Matthew J Singleton1, Ryan Brunetti1, Mark H Schoenfeld2, Prashant D Bhave1, David X Zhao1, S Patrick Whalen1.   

Abstract

Entities:  

Keywords:  Complication; Lead extraction; Occluder; Percutaneous; Pseudoaneurysm; Right ventricle

Year:  2019        PMID: 31890569      PMCID: PMC6926237          DOI: 10.1016/j.hrcr.2019.08.007

Source DB:  PubMed          Journal:  HeartRhythm Case Rep        ISSN: 2214-0271


× No keyword cloud information.

Introduction

With the steady increase in the prevalence of transvenous cardiac rhythm maintenance devices in the general population, the number of patients requiring lead extraction has grown proportionately. Though advances in the tools and techniques used for transvenous lead extraction have decreased the procedural morbidity, there remains a small but significant risk of catastrophic outcomes.2, 3, 4, 5 We describe a novel, percutaneous approach to management of a complication that would otherwise require sternotomy.

Case report

A 78-year-old man with a secondary-prevention implantable cardioverter-defibrillator for history of ventricular tachycardia and high-grade atrioventricular block, as well as a recalled right ventricular (RV) lead (St. Jude Medical Riata 1580 [St. Paul, MN], 16-year dwell time) and pulse generator at elective replacement, was referred for pulse generator change and lead extraction. He had no prior cardiac surgery. Preoperative fluoroscopy demonstrated RV lead cable externalization at multiple locations. A 14F GlideLight (Spectranetics, Colorado Springs, CO) laser sheath was employed, but it would not progress beyond the distal coil. Ultimately, a 13F TightRail (Spectranetics) and counter-traction were used to liberate the lead (Supplemental Figure 1). Twenty minutes after completion of the extraction and removal of the transesophageal echocardiography probe, the patient became acutely hypotensive, requiring escalating pressor doses and subsequently a brief period of cardiopulmonary resuscitation. Bedside echocardiogram demonstrated pericardial effusion with tamponade physiology. Emergent pericardiocentesis produced 300 mL of bloody fluid and normalization of blood pressure. His hospital course was complicated by a cardioembolic stroke and a large left-sided pleural effusion. Two weeks later, he was readmitted for dyspnea and chest pain in the setting of recurrent left-sided pleural effusions, which were attributed to congestive heart failure, trauma from chest compressions, and ongoing oral anticoagulation. He required repeated thoracenteses, each producing 1 L of bloody fluid, and a pleural drainage system was placed. Computed tomography of the chest demonstrated an RV apical pseudoaneurysm that measured 4.6 × 2.3 × 6.1 cm with a 7-mm neck (Figure 1). Anticoagulation was indicated, given atrial fibrillation and a history of cardioembolic stroke, but there was substantial concern about the risk of pseudoaneurysm expansion and rupture with anticoagulation. Cardiothoracic Surgery consulted for consideration of operative repair but judged the patient to have prohibitive operative risk, so percutaneous treatment was pursued.
Figure 1

Coronal reconstruction of computed tomographic scan prior to closure demonstrating right ventricular (RV) pseudoaneurysm emerging from the RV apex with a narrow neck, filling with contrast.

Coronal reconstruction of computed tomographic scan prior to closure demonstrating right ventricular (RV) pseudoaneurysm emerging from the RV apex with a narrow neck, filling with contrast. In the cardiac catheterization laboratory, right femoral venous access was obtained. Right ventriculography demonstrated the apical pseudoaneurysm (Figure 2A) filling briskly (Video 1). A j-tip wire (0.052 inch) was advanced into the pseudoaneurysm and position was confirmed by fluoroscopy (Figure 2B) and transesophageal echocardiography. A St. Jude Medical 8-mm Amplatzer ventricular septal defect occluder device was successfully deployed into the RV pseudoaneurysm, with postdeployment angiography demonstrating excellent device position (Supplemental Figure 2) with no residual flow across the neck of the pseudoaneurysm (Video 2). Repeat imaging 2 months later confirmed stability of the device and continued exclusion of the pseudoaneurysm (Figure 3).
Figure 2

A: Fluoroscopic view of contrast filling right ventricular pseudoaneurysm. B: J-tip wire in place prior to deployment of ventricular septal occluder device.

Figure 3

Coronal reconstruction of computed tomographic scan 2 months post-closure demonstrating obliteration of right ventricular (RV) pseudoaneurysm with radiodense septal occluder device visualized at the RV apex, where the pseudoaneurysm neck was previously.

A: Fluoroscopic view of contrast filling right ventricular pseudoaneurysm. B: J-tip wire in place prior to deployment of ventricular septal occluder device. Coronal reconstruction of computed tomographic scan 2 months post-closure demonstrating obliteration of right ventricular (RV) pseudoaneurysm with radiodense septal occluder device visualized at the RV apex, where the pseudoaneurysm neck was previously.

Discussion

RV pseudoaneurysm formation is a rare complication of lead extraction. In general, ventricular pseudoaneurysms portend a poor prognosis if managed conservatively and have traditionally required operative management.7, 8, 9 Prior studies have demonstrated the heightened risk of thromboembolism and ventricular free wall rupture when ventricular pseudoaneurysms are not surgically managed, with annual rupture rates of 30%–45%.10, 11 In patients who are not operative candidates, there have been several explorations into the possibility of percutaneous closure, with varying success.12, 13 Though the data on prognosis and management of left ventricular pseudoaneurysms are sparse, even less data are available on RV pseudoaneurysms, leaving uncertainty in the optimal management strategy. This patient had an RV pseudoaneurysm, which would traditionally be treated with open surgical aneurysmectomy, but his active comorbidities conferred prohibitive operative risk. Therefore an alternative option was required, and percutaneous treatment offered a less invasive solution. It should be noted that relationships of the pseudoaneurysm to adjacent cardiac structures, such as the valve annulus, outflow tract, and epicardial vessel, can limit percutaneous closure options. Our case illustrates the importance of collaborative clinical care, involving cardiac electrophysiology, cardiac surgery, and interventional cardiology. The patient tolerated deployment of the septal occluder device and demonstrated both clinical and radiographic success. He has had no further sequelae of his RV pseudoaneurysm and is doing well clinically.

Conclusion

We report successful percutaneous treatment of an RV pseudoaneurysm with a ventricular septal occluder device, with radiographically confirmed closure. As lead extractions become more and more common, percutaneous closure and other advanced techniques for treating downstream complications, such as iatrogenic ventricular pseudoaneurysms, may become increasingly relevant. Right ventricular pseudoaneurysm is a known complication of transvenous lead extraction. Ventricular pseudoaneurysms portend a poor prognosis and have traditionally required operative repair. Percutaneous closure of pseudoaneurysm with a ventricular septal occluder device was clinically and radiographically successful.
  14 in total

1.  Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States.

Authors:  Abhishek Deshmukh; Nileshkumar Patel; Peter A Noseworthy; Achint A Patel; Nilay Patel; Shilpkumar Arora; Suraj Kapa; Amit Noheria; Siva Mulpuru; Apurva Badheka; Avi Fischer; James O Coffey; Yong Mei Cha; Paul Friedman; Samuel Asirvatham; Juan F Viles-Gonzalez
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

2.  Surgical treatment of postinfarction left ventricular pseudoaneurysm.

Authors:  Fernando A Atik; Jose L Navia; Pablo Ruda Vega; Gonzalo V Gonzalez-Stawinski; Joan M Alster; A Marc Gillinov; Lars G Svensson; B Gösta Pettersson; Bruce W Lytle; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

3.  Right ventricular pseudoaneurysm after lead extraction.

Authors:  Thomas J McGarry; Brett Berman; Ulrika Birgersdotter-Green; Victor Pretorius
Journal:  Heart Rhythm       Date:  2014-03-06       Impact factor: 6.343

Review 4.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni
Journal:  Heart Rhythm       Date:  2017-09-15       Impact factor: 6.343

5.  Percutaneous Closure of a Left Ventricular Pseudoaneurysm Causing Recurrent Embolization, With Cerebral Protection and Extracorporeal Membrane Oxygenation Support.

Authors:  Marco Pavani; Innocenzo Scrocca; Emanuele Meliga; Mauro De Benedictis
Journal:  JACC Cardiovasc Interv       Date:  2017-11-15       Impact factor: 11.195

6.  Surgical treatment of acquired left ventricular pseudoaneurysms.

Authors:  R Prêtre; A Linka; R Jenni; M I Turina
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

7.  Percutaneous therapeutic approaches to closure of cardiac pseudoaneurysms.

Authors:  Prasanna Venkatesh Kumar; Oluseun Alli; Haruldur Bjarnason; Donald J Hagler; Thoralf M Sundt; Charanjit S Rihal
Journal:  Catheter Cardiovasc Interv       Date:  2012-04-17       Impact factor: 2.692

8.  Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.

Authors:  Nitesh Sood; David T Martin; Rachel Lampert; Jeptha P Curtis; Craig Parzynski; Jude Clancy
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-02-16

Review 9.  Left ventricular pseudoaneurysm.

Authors:  C Frances; A Romero; D Grady
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

10.  Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction.

Authors:  Robert G Hauser; William T Katsiyiannis; Charles C Gornick; Adrian K Almquist; Linda M Kallinen
Journal:  Europace       Date:  2009-11-27       Impact factor: 5.214

View more
  2 in total

1.  Employing Amplatzer Occluder® in Cardiac Free Wall Rupture Repair: A Scoping Study.

Authors:  Pramod Theetha Kariyanna; Ashkan Tadayoni; Amog Jayarangaiah; Sudhanva Hegde; Apoorva Jayaranagaiah; Moro O Salifu; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2020-05-22

2.  Right ventricular pseudoaneurysm causing very late tamponade: The leftover of a previously perforated and replaced defibrillator lead.

Authors:  Jens Kristensen; Mads Brix Kronborg; Kim Terp; Jesper Møller Jensen; Steen Buus Kristiansen; Jens Cosedis Nielsen
Journal:  HeartRhythm Case Rep       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.